Healthcare is an enormous sector, so it is not surprising that a few companies do not get quite all the attention they might merit. Two examples that reported within the last two weeks are Becton Dickinson (NYSE: BDX) and ICU Medical (Nasdaq: ICUI). Both companies tend to be under-appreciated because of what investors regard as low-potential and unexciting markets. A closer look, though, suggests there is still more than meets the eye with both stories.
The Quarters That Were
Becton did not help its case much this quarter with a performance that was okay but not great. Revenue rose 4% (in constant currency terms), with the strongest growth once again in the biosciences segment (up 12%, but only about 16% of overall revenue). Both the medical and diagnostic segments are suffering from difficult year-over-year comps due to last year's flu scare and an ongoing decline in physician office visits.
For the complete piece, please continue on to:
http://stocks.investopedia.com/stock-analysis/2010/Two-Under-The-Radar-Reports-In-Med-Tech-BDX-ICUI-HSP-HOLX-GPRO-CPHD-ABT0803.aspx
No comments:
Post a Comment